clinical trial · NCT07322991
Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.
Il-Yang Pharm. Co., Ltd.·phase1·completed·n = 43
Healthy Adult MaleIY001(Finasteride)IY002(Tamsulosin)
brief summary
The purpose of this stud is to evaluate the drug-drug interaction between IY001 and IY002 in adult males.
started
Oct 14, 2025
primary completion
Dec 1, 2025
completion
Dec 1, 2025
last updated
Jan 7, 2026
detailed description
The study is an Open-label, Phase I, drug-drug interaction study.
official title
A Phase 1 Clinical Trial With an Open-label, Single-agent Repeated Dosing Followed by Combined Repeated Dosing Design to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol